Tenuigenin and forsythoside A extracts from specific plants show neuro-protective effects individually. When combined in a 2:1 ratio, they synergistically protect against Alzheimer's disease symptoms in cell models. Shows potential for future treatment development.
Study on herbal formulation with Rhodiola, Tribulus, Undaria & Moringa shows reduced serotonin & dopamine turnover, increased GnRH gene expression, and potential stress relief & libido enhancement. Promising for combating stress and fatigue.
Researchers created vegan soups with potential Alzheimer's prevention properties by incorporating cholinesterase inhibitors. Important for understanding and potentially treating AD.
Nardostachys jatamansi DC. roots & rhizomes treat Parkinson's disease; Nardosinone, main active component, shows potential for PD treatment. Important for PD research & treatment development.
Ginsenoside Rb1 can mitigate aconitine-induced cardiotoxicity by reducing myocardial damage and restoring action potential and calcium signaling balance. This study shows potential for using Rb1 as a detoxifying agent in traditional Chinese medicine.
The study identified bioactive compounds in Alchornea laxiflora with potential antidepressant effects through molecular docking and network pharmacology. Key targets include SRC, EGFR, PIK3R1, AKT1, and MAPK1, suggesting a role in treating depression via PI3K-Akt and MAPK signaling pathways.
Scientists studied the effects of climate change on butterflies' host plants. They found that increased CO2 levels could lead to decreased plant quality, affecting butterfly populations. Important for understanding how climate change impacts ecosystems.
LY01, from Sophora alopecuroides L, shows neuroprotection and potential for ischemic stroke treatment. Further research needed for mechanism and efficacy.